Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 20880066)

1.

Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression.

Sakaki M, Makino R, Hiroishi K, Ueda K, Eguchi J, Hiraide A, Doi H, Omori R, Imawari M.

Hepatol Res. 2010 Dec;40(12):1219-26. doi: 10.1111/j.1872-034X.2010.00727.x. Epub 2010 Sep 28.

PMID:
20880066
2.

Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.

Miyashita M, Ito T, Sakaki M, Kajiwara A, Nozawa H, Hiroishi K, Kobayashi M, Kumada H, Imawari M.

J Viral Hepat. 2012 Sep;19(9):608-14. doi: 10.1111/j.1365-2893.2011.01580.x. Epub 2012 Jan 28.

PMID:
22863264
3.

SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.

Naito M, Matsui A, Inao M, Nagoshi S, Nagano M, Ito N, Egashira T, Hashimoto M, Mishiro S, Mochida S, Fujiwara K.

J Gastroenterol. 2005 Apr;40(4):381-8.

PMID:
15868370
4.

Cyclooxygenase 2 1195G > A polymorphism is associated with chronic obstructive pulmonary disease in Japanese and Chinese patients.

Chen LJ, Xu W, Taooka Y, Ohe M, Takahashi H, Sutani A, Kuraki T, Isobe T.

Chin Med J (Engl). 2013 Jun;126(12):2215-21.

PMID:
23786928
5.

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.

Núñez O, Fernández-Martínez A, Majano PL, Apolinario A, Gómez-Gonzalo M, Benedicto I, López-Cabrera M, Boscá L, Clemente G, García-Monzón C, Martín-Sanz P.

Gut. 2004 Nov;53(11):1665-72.

6.

[Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].

Xu DK, Zhang XM, Zhao P, Cai JC, Zhao D, Tan W, Guo YL, Lin DX.

Zhonghua Yi Xue Za Zhi. 2008 Jul 22;88(28):1961-5. Chinese.

PMID:
19062735
7.

Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.

Shi J, Misso NL, Kedda MA, Horn J, Welch MD, Duffy DL, Williams C, Thompson PJ.

Clin Exp Allergy. 2008 Jun;38(6):913-20. doi: 10.1111/j.1365-2222.2008.02986.x. Epub 2008 Apr 11.

PMID:
18489027
8.

Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients.

Mochida S, Hashimoto M, Matsui A, Naito M, Inao M, Nagoshi S, Nagano M, Egashira T, Mishiro S, Fujiwara K.

Biochem Biophys Res Commun. 2004 Jan 23;313(4):1079-85.

PMID:
14706653
9.

The -1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines.

Pereira C, Sousa H, Silva J, Brandão C, Elgueta-Karstegl C, Farrell PJ, Medeiros R, Dinis-Ribeiro M.

Mol Carcinog. 2014 Feb;53 Suppl 1:E92-5. doi: 10.1002/mc.22049. Epub 2013 Jun 18.

PMID:
23776069
10.

COX-2 polymorphisms in patients with familial adenomatous polyposis.

Peters WH, te Morsche RH, Roelofs HM, Mathus-Vliegen EM, Berkhout M, Nagengast FM.

Oncol Res. 2009;17(8):347-51.

PMID:
19544971
11.

[Associated study on interleukin 10 gene promoter polymorphisms related to hepatitis B virus infection in Chinese Han population].

Zhang PA, Li Y, Yang XS.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Aug;23(4):410-4. Chinese.

PMID:
16883528
12.

[Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD].

Cao MB, Yang YX, Dong L.

Zhonghua Gan Zang Bing Za Zhi. 2010 Oct;18(10):773-7. doi: 10.3760/cma.j.issn.1007-3418.2010.10.012. Chinese.

PMID:
21059296
13.
14.

Impact of the IL-18 gene polymorphism in response to antiviral therapy in chronic HCV genotype 4 patients.

Mandour M, Nemr N, Kishk R, Ahmed E.

Rev Soc Bras Med Trop. 2014 Mar-Apr;47(2):137-42.

15.

IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients.

Chuang JY, Yang SS, Lu YT, Hsieh YY, Chen CY, Chang SC, Chang CS, Yeh HZ, Kao JH.

Dig Liver Dis. 2009 Jun;41(6):424-30. doi: 10.1016/j.dld.2008.09.017. Epub 2008 Nov 11.

PMID:
19004675
16.

Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease.

El-Awady MK, Mostafa L, Tabll AA, Abdelhafez TH, Bader El Din NG, Zayed N, Shenawy RE, El Abd Y, Hasan RM, Zaghlol H, El Khayat H, Abdel Aziz AO.

Hepat Mon. 2012 Apr;12(4):271-7. doi: 10.5812/hepatmon.835. Epub 2012 Apr 30.

17.

[Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].

Zhang PA, Wu JM, Li Y, Yang XS.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Oct;22(5):528-32. Chinese.

PMID:
16215941
18.

Association of interferon-gamma induced protein 10 promoter polymorphisms with the disease progression of hepatitis B virus infection in Chinese Han population.

Xu Z, Liu Y, Liu L, Li X, Bai S, Rong Y, Wang H, Mao Y, Xin S, Xu D.

PLoS One. 2013 Sep 4;8(9):e72799. doi: 10.1371/journal.pone.0072799. eCollection 2013.

19.

Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.

Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH.

J Gastroenterol Hepatol. 2006 Jul;21(7):1163-9.

PMID:
16824070
20.

TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.

Askar E, Bregadze R, Mertens J, Schweyer S, Rosenberger A, Ramadori G, Mihm S.

J Med Virol. 2009 Jul;81(7):1204-11. doi: 10.1002/jmv.21491.

PMID:
19475618
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk